

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 4.93688594 |
| 2 | proline transport (GO:0015824) | 4.17117542 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.89835288 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.42268502 |
| 5 | response to dietary excess (GO:0002021) | 3.42207283 |
| 6 | locomotory exploration behavior (GO:0035641) | 3.42187659 |
| 7 | sodium ion export (GO:0071436) | 3.32824495 |
| 8 | histone H3-K4 trimethylation (GO:0080182) | 3.27919813 |
| 9 | iron ion import (GO:0097286) | 3.26723667 |
| 10 | cellular potassium ion homeostasis (GO:0030007) | 3.22019309 |
| 11 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.22017838 |
| 12 | glutamate secretion (GO:0014047) | 3.21763076 |
| 13 | vocalization behavior (GO:0071625) | 3.20734404 |
| 14 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 3.18869724 |
| 15 | intestinal epithelial cell development (GO:0060576) | 3.13753973 |
| 16 | synaptic vesicle exocytosis (GO:0016079) | 3.07943765 |
| 17 | cellular response to ethanol (GO:0071361) | 3.07943406 |
| 18 | hormone catabolic process (GO:0042447) | 3.04532799 |
| 19 | carnitine shuttle (GO:0006853) | 3.03764720 |
| 20 | daunorubicin metabolic process (GO:0044597) | 2.98071441 |
| 21 | polyketide metabolic process (GO:0030638) | 2.98071441 |
| 22 | doxorubicin metabolic process (GO:0044598) | 2.98071441 |
| 23 | detection of temperature stimulus (GO:0016048) | 2.97361752 |
| 24 | layer formation in cerebral cortex (GO:0021819) | 2.95752127 |
| 25 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.93087057 |
| 26 | myeloid leukocyte mediated immunity (GO:0002444) | 2.91222927 |
| 27 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.90575073 |
| 28 | gamma-aminobutyric acid transport (GO:0015812) | 2.88664468 |
| 29 | carnitine transmembrane transport (GO:1902603) | 2.85760339 |
| 30 | fatty acid transmembrane transport (GO:1902001) | 2.84346289 |
| 31 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.82054174 |
| 32 | nerve growth factor signaling pathway (GO:0038180) | 2.79443220 |
| 33 | neurotransmitter secretion (GO:0007269) | 2.78114501 |
| 34 | protein targeting to Golgi (GO:0000042) | 2.76948061 |
| 35 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.76789811 |
| 36 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.76733512 |
| 37 | branching involved in prostate gland morphogenesis (GO:0060442) | 2.76329625 |
| 38 | carnitine transport (GO:0015879) | 2.74840477 |
| 39 | amino-acid betaine transport (GO:0015838) | 2.74840477 |
| 40 | coenzyme catabolic process (GO:0009109) | 2.74212733 |
| 41 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.68725414 |
| 42 | positive regulation of macrophage cytokine production (GO:0060907) | 2.67184341 |
| 43 | regulation of ARF protein signal transduction (GO:0032012) | 2.66655714 |
| 44 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.66311888 |
| 45 | maintenance of protein location in nucleus (GO:0051457) | 2.66220508 |
| 46 | cellular modified amino acid catabolic process (GO:0042219) | 2.64385918 |
| 47 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.63927074 |
| 48 | glycine transport (GO:0015816) | 2.62178860 |
| 49 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.61784350 |
| 50 | cerebellar granule cell differentiation (GO:0021707) | 2.59290588 |
| 51 | striated muscle atrophy (GO:0014891) | 2.58968243 |
| 52 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.58172600 |
| 53 | regulation of synaptic vesicle transport (GO:1902803) | 2.57132088 |
| 54 | establishment of protein localization to Golgi (GO:0072600) | 2.56621433 |
| 55 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.54779909 |
| 56 | biotin metabolic process (GO:0006768) | 2.54624811 |
| 57 | positive regulation of synapse maturation (GO:0090129) | 2.53866273 |
| 58 | regulation of synapse structural plasticity (GO:0051823) | 2.52871058 |
| 59 | opsonization (GO:0008228) | 2.52465596 |
| 60 | early endosome to late endosome transport (GO:0045022) | 2.51505303 |
| 61 | glutamate receptor signaling pathway (GO:0007215) | 2.50872767 |
| 62 | neuronal action potential propagation (GO:0019227) | 2.50451993 |
| 63 | synaptic vesicle endocytosis (GO:0048488) | 2.50305428 |
| 64 | alanine transport (GO:0032328) | 2.49944047 |
| 65 | skeletal muscle adaptation (GO:0043501) | 2.49894306 |
| 66 | synaptic transmission, glutamatergic (GO:0035249) | 2.48109454 |
| 67 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.47066524 |
| 68 | auditory receptor cell differentiation (GO:0042491) | 2.45455426 |
| 69 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.45313147 |
| 70 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.44563085 |
| 71 | neuromuscular process controlling balance (GO:0050885) | 2.41757986 |
| 72 | dendrite morphogenesis (GO:0048813) | 2.40606562 |
| 73 | L-amino acid import (GO:0043092) | 2.40226074 |
| 74 | histone H3-K36 demethylation (GO:0070544) | 2.39773351 |
| 75 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.39560802 |
| 76 | regulation of gamma-delta T cell activation (GO:0046643) | 2.39538203 |
| 77 | interkinetic nuclear migration (GO:0022027) | 2.38958561 |
| 78 | neurotransmitter transport (GO:0006836) | 2.38680247 |
| 79 | exploration behavior (GO:0035640) | 2.38662164 |
| 80 | protein localization to synapse (GO:0035418) | 2.38381481 |
| 81 | cellular sodium ion homeostasis (GO:0006883) | 2.38370744 |
| 82 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.37939245 |
| 83 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.36255949 |
| 84 | positive regulation of fatty acid oxidation (GO:0046321) | 2.35478113 |
| 85 | lysosome organization (GO:0007040) | 2.35367298 |
| 86 | lytic vacuole organization (GO:0080171) | 2.35367298 |
| 87 | membrane depolarization during action potential (GO:0086010) | 2.34980000 |
| 88 | lipid translocation (GO:0034204) | 2.34866571 |
| 89 | phospholipid translocation (GO:0045332) | 2.34866571 |
| 90 | regulation of macrophage cytokine production (GO:0010935) | 2.34390958 |
| 91 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.33591591 |
| 92 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.33591591 |
| 93 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.33227346 |
| 94 | cell communication by electrical coupling (GO:0010644) | 2.31327745 |
| 95 | defense response to fungus (GO:0050832) | 2.30929108 |
| 96 | lung epithelial cell differentiation (GO:0060487) | 2.30877893 |
| 97 | activation of protein kinase A activity (GO:0034199) | 2.30528344 |
| 98 | somite rostral/caudal axis specification (GO:0032525) | 2.29181475 |
| 99 | peptidyl-lysine trimethylation (GO:0018023) | 2.29053806 |
| 100 | import into cell (GO:0098657) | 2.28879828 |
| 101 | regulation of Rap GTPase activity (GO:0032317) | 2.28878892 |
| 102 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.28402287 |
| 103 | vesicle transport along microtubule (GO:0047496) | 2.27866909 |
| 104 | positive regulation of Rap GTPase activity (GO:0032854) | 2.27297184 |
| 105 | potassium ion import (GO:0010107) | 2.26897476 |
| 106 | long-term memory (GO:0007616) | 2.26033996 |
| 107 | macroautophagy (GO:0016236) | 2.25945555 |
| 108 | histone H3-K4 methylation (GO:0051568) | 2.25525478 |
| 109 | regulation of receptor binding (GO:1900120) | 2.25416926 |
| 110 | mannose metabolic process (GO:0006013) | 2.25348946 |
| 111 | neuromuscular process controlling posture (GO:0050884) | 2.25169222 |
| 112 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.24790388 |
| 113 | L-fucose metabolic process (GO:0042354) | 2.24502114 |
| 114 | L-fucose catabolic process (GO:0042355) | 2.24502114 |
| 115 | fucose catabolic process (GO:0019317) | 2.24502114 |
| 116 | mitochondrion distribution (GO:0048311) | 2.24264485 |
| 117 | epithelial cell maturation (GO:0002070) | 2.23888730 |
| 118 | positive regulation of steroid hormone secretion (GO:2000833) | 2.22868621 |
| 119 | sulfur amino acid catabolic process (GO:0000098) | 2.22419577 |
| 120 | cellular extravasation (GO:0045123) | 2.22246929 |
| 121 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.20772219 |
| 122 | positive regulation of bone remodeling (GO:0046852) | 2.20693419 |
| 123 | positive regulation of bone resorption (GO:0045780) | 2.20693419 |
| 124 | response to lipoprotein particle (GO:0055094) | 2.20600376 |
| 125 | striatum development (GO:0021756) | 2.20543542 |
| 126 | macrophage activation involved in immune response (GO:0002281) | 2.20228720 |
| 127 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.20061883 |
| 128 | potassium ion homeostasis (GO:0055075) | 2.20001883 |
| 129 | neutral amino acid transport (GO:0015804) | 2.19450961 |
| 130 | activated T cell proliferation (GO:0050798) | 2.18897897 |
| 131 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.18815532 |
| 132 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.18630068 |
| 133 | regulation of fatty acid oxidation (GO:0046320) | 2.18444343 |
| 134 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.17157444 |
| 135 | neuron-neuron synaptic transmission (GO:0007270) | 2.17105846 |
| 136 | regulation of beta-amyloid formation (GO:1902003) | 2.16777869 |
| 137 | regulation of cholesterol homeostasis (GO:2000188) | 2.16598982 |
| 138 | cell migration in hindbrain (GO:0021535) | 2.16169855 |
| 139 | lung cell differentiation (GO:0060479) | 2.15328648 |
| 140 | quaternary ammonium group transport (GO:0015697) | 2.14598866 |
| 141 | cell communication involved in cardiac conduction (GO:0086065) | 2.14427907 |
| 142 | dendritic spine morphogenesis (GO:0060997) | 2.13739347 |
| 143 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.13703032 |
| 144 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.13558655 |
| 145 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.13224117 |
| 146 | response to auditory stimulus (GO:0010996) | 2.13109998 |
| 147 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.12868454 |
| 148 | regulation of response to osmotic stress (GO:0047484) | 2.12591243 |
| 149 | regulation of neurotransmitter levels (GO:0001505) | 2.12356806 |
| 150 | transmission of nerve impulse (GO:0019226) | 2.12072123 |
| 151 | organelle transport along microtubule (GO:0072384) | 2.12032750 |
| 152 | cell differentiation in hindbrain (GO:0021533) | 2.10762429 |
| 153 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.10744451 |
| 154 | sulfate transmembrane transport (GO:1902358) | 2.09995576 |
| 155 | positive regulation of histone deacetylation (GO:0031065) | 2.09283229 |
| 156 | piRNA metabolic process (GO:0034587) | 2.08847145 |
| 157 | regulation of ARF GTPase activity (GO:0032312) | 2.08377540 |
| 158 | nitric oxide biosynthetic process (GO:0006809) | 2.08337967 |
| 159 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.07896700 |
| 160 | response to peptidoglycan (GO:0032494) | 2.06697142 |
| 161 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.06580982 |
| 162 | negative regulation of cell killing (GO:0031342) | 2.06580982 |
| 163 | regulation of protein polyubiquitination (GO:1902914) | 2.05943222 |
| 164 | protein targeting to lysosome (GO:0006622) | 2.05940824 |
| 165 | establishment of protein localization to vacuole (GO:0072666) | 2.05940824 |
| 166 | protein targeting to vacuole (GO:0006623) | 2.05940824 |
| 167 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.03952615 |
| 168 | histone lysine methylation (GO:0034968) | 2.02781036 |
| 169 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.00906215 |
| 170 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.00458721 |
| 171 | phospholipid dephosphorylation (GO:0046839) | 2.00125987 |
| 172 | artery development (GO:0060840) | 1.98775951 |
| 173 | peptidyl-lysine methylation (GO:0018022) | 1.98211539 |
| 174 | phosphatidylinositol dephosphorylation (GO:0046856) | 1.97433723 |
| 175 | positive regulation of mast cell activation (GO:0033005) | 1.96832429 |
| 176 | neutrophil activation (GO:0042119) | 1.96276638 |
| 177 | regulation of establishment of cell polarity (GO:2000114) | 1.94139603 |
| 178 | mitochondrion degradation (GO:0000422) | 1.93415680 |
| 179 | melanocyte differentiation (GO:0030318) | 1.92977926 |
| 180 | pharyngeal system development (GO:0060037) | 1.91561211 |
| 181 | regulation of mast cell activation (GO:0033003) | 1.90838309 |
| 182 | intracellular lipid transport (GO:0032365) | 1.90147247 |
| 183 | muscle atrophy (GO:0014889) | 1.89844497 |
| 184 | positive regulation of macroautophagy (GO:0016239) | 1.89316089 |
| 185 | detection of molecule of bacterial origin (GO:0032490) | 1.88412906 |
| 186 | regulation of cilium assembly (GO:1902017) | 1.88258912 |
| 187 | regulation of hippo signaling (GO:0035330) | 1.87717564 |
| 188 | negative regulation of macrophage differentiation (GO:0045650) | 1.87540593 |
| 189 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 1.86729460 |
| 190 | oligosaccharide catabolic process (GO:0009313) | 1.85852989 |
| 191 | production of molecular mediator involved in inflammatory response (GO:0002532) | 1.85652199 |
| 192 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 1.85479438 |
| 193 | negative regulation of fatty acid transport (GO:2000192) | 1.85211800 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.50687427 |
| 2 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.47878770 |
| 3 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.31620478 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.22665572 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.17526953 |
| 6 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.06633313 |
| 7 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.05488782 |
| 8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.04462408 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.01611137 |
| 10 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.99499926 |
| 11 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.98695704 |
| 12 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.94997430 |
| 13 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.93010928 |
| 14 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.89682377 |
| 15 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.88608549 |
| 16 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.84320650 |
| 17 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.82332736 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.78207195 |
| 19 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.77727464 |
| 20 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.77340290 |
| 21 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.77340290 |
| 22 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.76947798 |
| 23 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.69216986 |
| 24 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.68383238 |
| 25 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.67190644 |
| 26 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.67190644 |
| 27 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.67190644 |
| 28 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.65901084 |
| 29 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.61969752 |
| 30 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.60243734 |
| 31 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.58893464 |
| 32 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.54184257 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.53962868 |
| 34 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.51598758 |
| 35 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.50496838 |
| 36 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.49965817 |
| 37 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.49359315 |
| 38 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.49181433 |
| 39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.49082145 |
| 40 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.47186245 |
| 41 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.46987736 |
| 42 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.45645056 |
| 43 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.42358409 |
| 44 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.42182426 |
| 45 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.39307005 |
| 46 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.37601220 |
| 47 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.36220690 |
| 48 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.35314546 |
| 49 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.34495602 |
| 50 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.34319623 |
| 51 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.33519941 |
| 52 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32715759 |
| 53 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.31000630 |
| 54 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.30353388 |
| 55 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.29685585 |
| 56 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.29491442 |
| 57 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.28000662 |
| 58 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.27830193 |
| 59 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.27612247 |
| 60 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.27551287 |
| 61 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.25705697 |
| 62 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.25294806 |
| 63 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.23886165 |
| 64 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.23472797 |
| 65 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.22654325 |
| 66 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.22165756 |
| 67 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.21812413 |
| 68 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17390822 |
| 69 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.16318015 |
| 70 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.15876467 |
| 71 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.15497142 |
| 72 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14314995 |
| 73 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.13338462 |
| 74 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.12472792 |
| 75 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.10614926 |
| 76 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.08890613 |
| 77 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08725175 |
| 78 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08569084 |
| 79 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.07724567 |
| 80 | * ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.06806452 |
| 81 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.06724521 |
| 82 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06578077 |
| 83 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06282213 |
| 84 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.05571824 |
| 85 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.05264021 |
| 86 | AR_19668381_ChIP-Seq_PC3_Human | 1.04941358 |
| 87 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.02485995 |
| 88 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.02217266 |
| 89 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00598534 |
| 90 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.00149939 |
| 91 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.99764043 |
| 92 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.99657885 |
| 93 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99654641 |
| 94 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98731589 |
| 95 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.98731589 |
| 96 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98692647 |
| 97 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.98358521 |
| 98 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97797941 |
| 99 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97033331 |
| 100 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.95213776 |
| 101 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.94646317 |
| 102 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.94641486 |
| 103 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.94519178 |
| 104 | AR_25329375_ChIP-Seq_VCAP_Human | 0.94129840 |
| 105 | * OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.94055950 |
| 106 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.93909946 |
| 107 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93509233 |
| 108 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.93180876 |
| 109 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.93165649 |
| 110 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.93147763 |
| 111 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.92946058 |
| 112 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.92853092 |
| 113 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.92819650 |
| 114 | RXR_22108803_ChIP-Seq_LS180_Human | 0.92521702 |
| 115 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.92220244 |
| 116 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.92171073 |
| 117 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.92061633 |
| 118 | TCF4_23295773_ChIP-Seq_U87_Human | 0.91860162 |
| 119 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.90913476 |
| 120 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.90144671 |
| 121 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.89852260 |
| 122 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.89032773 |
| 123 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.88647782 |
| 124 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.88457951 |
| 125 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.87431928 |
| 126 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.87394551 |
| 127 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.86990363 |
| 128 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.86921049 |
| 129 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.86624151 |
| 130 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.86305250 |
| 131 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85214752 |
| 132 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.84831756 |
| 133 | * SPI1_23127762_ChIP-Seq_K562_Human | 0.84775875 |
| 134 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.83619789 |
| 135 | * NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.83433828 |
| 136 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83246291 |
| 137 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.83166037 |
| 138 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.82977996 |
| 139 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.82893104 |
| 140 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.82828372 |
| 141 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.82405340 |
| 142 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.81463022 |
| 143 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.81143766 |
| 144 | GATA1_19941826_ChIP-Seq_K562_Human | 0.80940925 |
| 145 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.79424536 |
| 146 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.78579318 |
| 147 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.78490038 |
| 148 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.78401760 |
| 149 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.78307260 |
| 150 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.77964072 |
| 151 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.77811581 |
| 152 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76617058 |
| 153 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.76592021 |
| 154 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.76021388 |
| 155 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.76013648 |
| 156 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.75847712 |
| 157 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.75565752 |
| 158 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.75417362 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.67100642 |
| 2 | MP0002009_preneoplasia | 4.27938648 |
| 3 | MP0004858_abnormal_nervous_system | 3.63185679 |
| 4 | MP0004270_analgesia | 3.41746925 |
| 5 | MP0002254_reproductive_system_inflammat | 3.16127641 |
| 6 | MP0002166_altered_tumor_susceptibility | 3.08869099 |
| 7 | MP0002822_catalepsy | 2.87720728 |
| 8 | MP0003635_abnormal_synaptic_transmissio | 2.78474674 |
| 9 | MP0009046_muscle_twitch | 2.60341452 |
| 10 | MP0000537_abnormal_urethra_morphology | 2.38229898 |
| 11 | MP0002909_abnormal_adrenal_gland | 2.37073995 |
| 12 | MP0003329_amyloid_beta_deposits | 2.33154708 |
| 13 | MP0002064_seizures | 2.32582604 |
| 14 | MP0003646_muscle_fatigue | 2.32388247 |
| 15 | MP0002063_abnormal_learning/memory/cond | 2.25110747 |
| 16 | MP0008961_abnormal_basal_metabolism | 2.21012260 |
| 17 | MP0003183_abnormal_peptide_metabolism | 2.20849227 |
| 18 | MP0009745_abnormal_behavioral_response | 2.18372819 |
| 19 | MP0004264_abnormal_extraembryonic_tissu | 2.14045898 |
| 20 | MP0003880_abnormal_central_pattern | 2.11523404 |
| 21 | MP0002734_abnormal_mechanical_nocicepti | 2.08677901 |
| 22 | MP0005645_abnormal_hypothalamus_physiol | 2.04680877 |
| 23 | MP0005360_urolithiasis | 2.04396538 |
| 24 | MP0001486_abnormal_startle_reflex | 2.03575240 |
| 25 | MP0002572_abnormal_emotion/affect_behav | 2.03155909 |
| 26 | MP0001501_abnormal_sleep_pattern | 1.97873893 |
| 27 | MP0001873_stomach_inflammation | 1.95661122 |
| 28 | MP0003172_abnormal_lysosome_physiology | 1.85452425 |
| 29 | MP0002733_abnormal_thermal_nociception | 1.84775415 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.83621929 |
| 31 | MP0002272_abnormal_nervous_system | 1.79922304 |
| 32 | MP0002006_tumorigenesis | 1.76697968 |
| 33 | MP0005499_abnormal_olfactory_system | 1.73144434 |
| 34 | MP0005394_taste/olfaction_phenotype | 1.73144434 |
| 35 | MP0000604_amyloidosis | 1.71523027 |
| 36 | MP0000538_abnormal_urinary_bladder | 1.65059252 |
| 37 | MP0009780_abnormal_chondrocyte_physiolo | 1.64374493 |
| 38 | MP0002139_abnormal_hepatobiliary_system | 1.60618993 |
| 39 | MP0005085_abnormal_gallbladder_physiolo | 1.57416412 |
| 40 | MP0001970_abnormal_pain_threshold | 1.57029500 |
| 41 | MP0002332_abnormal_exercise_endurance | 1.56764628 |
| 42 | MP0005365_abnormal_bile_salt | 1.54855509 |
| 43 | MP0000569_abnormal_digit_pigmentation | 1.54227899 |
| 44 | MP0002876_abnormal_thyroid_physiology | 1.53397962 |
| 45 | MP0002735_abnormal_chemical_nociception | 1.51687171 |
| 46 | MP0003690_abnormal_glial_cell | 1.49919919 |
| 47 | MP0000955_abnormal_spinal_cord | 1.49427936 |
| 48 | MP0005646_abnormal_pituitary_gland | 1.49187924 |
| 49 | MP0003724_increased_susceptibility_to | 1.48273429 |
| 50 | MP0004381_abnormal_hair_follicle | 1.47689392 |
| 51 | MP0004130_abnormal_muscle_cell | 1.47047878 |
| 52 | MP0003045_fibrosis | 1.46590981 |
| 53 | MP0001968_abnormal_touch/_nociception | 1.45604032 |
| 54 | MP0005451_abnormal_body_composition | 1.44666087 |
| 55 | MP0001765_abnormal_ion_homeostasis | 1.42844019 |
| 56 | MP0008569_lethality_at_weaning | 1.42822941 |
| 57 | MP0004036_abnormal_muscle_relaxation | 1.40469309 |
| 58 | MP0003075_altered_response_to | 1.39000659 |
| 59 | MP0010234_abnormal_vibrissa_follicle | 1.38968227 |
| 60 | MP0008875_abnormal_xenobiotic_pharmacok | 1.38547312 |
| 61 | MP0003252_abnormal_bile_duct | 1.38273173 |
| 62 | MP0001440_abnormal_grooming_behavior | 1.36316990 |
| 63 | MP0003633_abnormal_nervous_system | 1.35709354 |
| 64 | MP0004043_abnormal_pH_regulation | 1.35067919 |
| 65 | MP0000015_abnormal_ear_pigmentation | 1.34342709 |
| 66 | MP0010329_abnormal_lipoprotein_level | 1.33659237 |
| 67 | MP0000516_abnormal_urinary_system | 1.32363068 |
| 68 | MP0005367_renal/urinary_system_phenotyp | 1.32363068 |
| 69 | MP0002184_abnormal_innervation | 1.29269192 |
| 70 | MP0001664_abnormal_digestion | 1.25894335 |
| 71 | MP0005423_abnormal_somatic_nervous | 1.23975277 |
| 72 | MP0005647_abnormal_sex_gland | 1.23367310 |
| 73 | MP0004811_abnormal_neuron_physiology | 1.23212554 |
| 74 | MP0008874_decreased_physiological_sensi | 1.22606871 |
| 75 | MP0002067_abnormal_sensory_capabilities | 1.21740288 |
| 76 | MP0000778_abnormal_nervous_system | 1.18408190 |
| 77 | MP0001835_abnormal_antigen_presentation | 1.17403721 |
| 78 | MP0002090_abnormal_vision | 1.17347854 |
| 79 | MP0003705_abnormal_hypodermis_morpholog | 1.16999768 |
| 80 | MP0000920_abnormal_myelination | 1.16528521 |
| 81 | MP0003866_abnormal_defecation | 1.16490659 |
| 82 | MP0000470_abnormal_stomach_morphology | 1.15484696 |
| 83 | MP0000383_abnormal_hair_follicle | 1.15099966 |
| 84 | MP0003011_delayed_dark_adaptation | 1.14789889 |
| 85 | MP0000427_abnormal_hair_cycle | 1.13772370 |
| 86 | MP0003195_calcinosis | 1.13591636 |
| 87 | MP0008872_abnormal_physiological_respon | 1.11506520 |
| 88 | MP0010678_abnormal_skin_adnexa | 1.11120350 |
| 89 | MP0003787_abnormal_imprinting | 1.10203376 |
| 90 | MP0004185_abnormal_adipocyte_glucose | 1.09872360 |
| 91 | MP0001919_abnormal_reproductive_system | 1.08637492 |
| 92 | MP0002229_neurodegeneration | 1.08255834 |
| 93 | MP0003122_maternal_imprinting | 1.07503119 |
| 94 | MP0001984_abnormal_olfaction | 1.07386614 |
| 95 | MP0002419_abnormal_innate_immunity | 1.06270011 |
| 96 | MP0005174_abnormal_tail_pigmentation | 1.06232757 |
| 97 | MP0010386_abnormal_urinary_bladder | 1.05769067 |
| 98 | MP0006082_CNS_inflammation | 1.05622667 |
| 99 | MP0003283_abnormal_digestive_organ | 1.05468693 |
| 100 | MP0005409_darkened_coat_color | 1.05293427 |
| 101 | MP0003315_abnormal_perineum_morphology | 1.05234105 |
| 102 | MP0004885_abnormal_endolymph | 1.04848466 |
| 103 | MP0002557_abnormal_social/conspecific_i | 1.04698933 |
| 104 | MP0003191_abnormal_cellular_cholesterol | 1.03539612 |
| 105 | MP0003890_abnormal_embryonic-extraembry | 1.03050467 |
| 106 | MP0005310_abnormal_salivary_gland | 1.01698048 |
| 107 | MP0003631_nervous_system_phenotype | 1.01656593 |
| 108 | MP0002882_abnormal_neuron_morphology | 1.01636554 |
| 109 | MP0000371_diluted_coat_color | 1.01525146 |
| 110 | MP0003632_abnormal_nervous_system | 1.01495359 |
| 111 | MP0003634_abnormal_glial_cell | 1.01307468 |
| 112 | MP0001790_abnormal_immune_system | 1.00886184 |
| 113 | MP0005387_immune_system_phenotype | 1.00886184 |
| 114 | MP0004142_abnormal_muscle_tone | 1.00284367 |
| 115 | MP0005671_abnormal_response_to | 1.00214342 |
| 116 | MP0009840_abnormal_foam_cell | 0.99538243 |
| 117 | MP0005248_abnormal_Harderian_gland | 0.96950695 |
| 118 | MP0002066_abnormal_motor_capabilities/c | 0.95032417 |
| 119 | MP0004233_abnormal_muscle_weight | 0.95018870 |
| 120 | MP0003828_pulmonary_edema | 0.94530844 |
| 121 | MP0005075_abnormal_melanosome_morpholog | 0.94209876 |
| 122 | MP0004145_abnormal_muscle_electrophysio | 0.92656642 |
| 123 | MP0005025_abnormal_response_to | 0.92639880 |
| 124 | MP0002693_abnormal_pancreas_physiology | 0.89411471 |
| 125 | MP0002118_abnormal_lipid_homeostasis | 0.89025407 |
| 126 | MP0005386_behavior/neurological_phenoty | 0.88948975 |
| 127 | MP0004924_abnormal_behavior | 0.88948975 |
| 128 | MP0005083_abnormal_biliary_tract | 0.88149474 |
| 129 | MP0005167_abnormal_blood-brain_barrier | 0.87754017 |
| 130 | MP0002069_abnormal_eating/drinking_beha | 0.87538840 |
| 131 | MP0005076_abnormal_cell_differentiation | 0.86871160 |
| 132 | MP0001800_abnormal_humoral_immune | 0.86836767 |
| 133 | MP0003436_decreased_susceptibility_to | 0.86786425 |
| 134 | MP0002653_abnormal_ependyma_morphology | 0.86704589 |
| 135 | MP0004510_myositis | 0.84836692 |
| 136 | MP0006292_abnormal_olfactory_placode | 0.84461214 |
| 137 | MP0002736_abnormal_nociception_after | 0.84308101 |
| 138 | MP0002138_abnormal_hepatobiliary_system | 0.83791253 |
| 139 | MP0005535_abnormal_body_temperature | 0.83744605 |
| 140 | MP0000685_abnormal_immune_system | 0.83474450 |
| 141 | MP0001756_abnormal_urination | 0.81869786 |
| 142 | MP0004883_abnormal_blood_vessel | 0.79629624 |
| 143 | MP0002452_abnormal_antigen_presenting | 0.79202614 |
| 144 | MP0010155_abnormal_intestine_physiology | 0.78125121 |
| 145 | MP0003137_abnormal_impulse_conducting | 0.77976296 |
| 146 | MP0006035_abnormal_mitochondrial_morpho | 0.77773038 |
| 147 | MP0003879_abnormal_hair_cell | 0.77227457 |
| 148 | MP0002168_other_aberrant_phenotype | 0.76937290 |
| 149 | MP0003300_gastrointestinal_ulcer | 0.76691615 |
| 150 | MP0001849_ear_inflammation | 0.76609885 |
| 151 | MP0005551_abnormal_eye_electrophysiolog | 0.75899786 |
| 152 | MP0005448_abnormal_energy_balance | 0.75859628 |
| 153 | MP0001348_abnormal_lacrimal_gland | 0.75721098 |
| 154 | MP0002971_abnormal_brown_adipose | 0.75419681 |
| 155 | MP0002078_abnormal_glucose_homeostasis | 0.75030819 |
| 156 | MP0000609_abnormal_liver_physiology | 0.74726710 |
| 157 | MP0004085_abnormal_heartbeat | 0.74642345 |
| 158 | MP0001663_abnormal_digestive_system | 0.74536087 |
| 159 | MP0001666_abnormal_nutrient_absorption | 0.74399076 |
| 160 | MP0002148_abnormal_hypersensitivity_rea | 0.73436215 |
| 161 | MP0002723_abnormal_immune_serum | 0.71988607 |
| 162 | MP0004947_skin_inflammation | 0.71675773 |
| 163 | MP0001764_abnormal_homeostasis | 0.69569599 |
| 164 | MP0001845_abnormal_inflammatory_respons | 0.68680808 |
| 165 | MP0004484_altered_response_of | 0.66934675 |
| 166 | MP0001533_abnormal_skeleton_physiology | 0.66725280 |
| 167 | MP0002896_abnormal_bone_mineralization | 0.64977922 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the lower motor neuron (HP:0002366) | 4.85332834 |
| 2 | Hypochromic microcytic anemia (HP:0004840) | 4.25373800 |
| 3 | Prostate neoplasm (HP:0100787) | 3.91762247 |
| 4 | Focal seizures (HP:0007359) | 3.91541014 |
| 5 | Supranuclear gaze palsy (HP:0000605) | 3.90314596 |
| 6 | Calf muscle hypertrophy (HP:0008981) | 3.79089047 |
| 7 | Myokymia (HP:0002411) | 3.71818978 |
| 8 | Hepatoblastoma (HP:0002884) | 3.54966605 |
| 9 | Testicular atrophy (HP:0000029) | 3.54786109 |
| 10 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.52221805 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 3.46622288 |
| 12 | Bilateral microphthalmos (HP:0007633) | 3.46331576 |
| 13 | Vacuolated lymphocytes (HP:0001922) | 3.45341030 |
| 14 | Focal motor seizures (HP:0011153) | 3.42781298 |
| 15 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.37899832 |
| 16 | Epileptic encephalopathy (HP:0200134) | 3.34492934 |
| 17 | J-shaped sella turcica (HP:0002680) | 3.32643515 |
| 18 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.31125041 |
| 19 | Action tremor (HP:0002345) | 3.29585976 |
| 20 | Abnormality of the 1st metacarpal (HP:0010009) | 3.29386297 |
| 21 | Febrile seizures (HP:0002373) | 3.27920734 |
| 22 | Neurofibrillary tangles (HP:0002185) | 3.23220480 |
| 23 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 3.22484416 |
| 24 | Short 1st metacarpal (HP:0010034) | 3.22484416 |
| 25 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.12243327 |
| 26 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.12243327 |
| 27 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.12243327 |
| 28 | Abnormality of the corticospinal tract (HP:0002492) | 3.07945376 |
| 29 | Hemiparesis (HP:0001269) | 3.07256015 |
| 30 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.07034751 |
| 31 | Mucopolysacchariduria (HP:0008155) | 3.07034751 |
| 32 | Hyperventilation (HP:0002883) | 3.06600028 |
| 33 | Amyotrophic lateral sclerosis (HP:0007354) | 3.05269472 |
| 34 | Visual hallucinations (HP:0002367) | 3.02685020 |
| 35 | Tetraplegia (HP:0002445) | 3.02234909 |
| 36 | Dysostosis multiplex (HP:0000943) | 3.00875845 |
| 37 | Dialeptic seizures (HP:0011146) | 2.99451652 |
| 38 | Abnormality of the axillary hair (HP:0100134) | 2.95579662 |
| 39 | Abnormality of secondary sexual hair (HP:0009888) | 2.95579662 |
| 40 | Neoplasm of the heart (HP:0100544) | 2.93069326 |
| 41 | Status epilepticus (HP:0002133) | 2.88066261 |
| 42 | Broad face (HP:0000283) | 2.85272446 |
| 43 | Cerebral inclusion bodies (HP:0100314) | 2.80408517 |
| 44 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.79047080 |
| 45 | Flat acetabular roof (HP:0003180) | 2.77025931 |
| 46 | Absence seizures (HP:0002121) | 2.68786337 |
| 47 | Spastic tetraparesis (HP:0001285) | 2.68539808 |
| 48 | Cheilitis (HP:0100825) | 2.68396339 |
| 49 | Generalized tonic-clonic seizures (HP:0002069) | 2.66521259 |
| 50 | Neuronal loss in central nervous system (HP:0002529) | 2.62209355 |
| 51 | Atonic seizures (HP:0010819) | 2.61026450 |
| 52 | Skin nodule (HP:0200036) | 2.58527495 |
| 53 | Difficulty running (HP:0009046) | 2.58301500 |
| 54 | Intention tremor (HP:0002080) | 2.58024712 |
| 55 | Testicular neoplasm (HP:0010788) | 2.56132077 |
| 56 | Dysmetric saccades (HP:0000641) | 2.52303860 |
| 57 | Hand muscle atrophy (HP:0009130) | 2.51328698 |
| 58 | Abnormality of the fingertips (HP:0001211) | 2.51088218 |
| 59 | Short phalanx of the thumb (HP:0009660) | 2.51082196 |
| 60 | Upper limb amyotrophy (HP:0009129) | 2.50938030 |
| 61 | Distal upper limb amyotrophy (HP:0007149) | 2.50938030 |
| 62 | Ankle clonus (HP:0011448) | 2.50198131 |
| 63 | Clumsiness (HP:0002312) | 2.49533210 |
| 64 | Dysmetria (HP:0001310) | 2.47965638 |
| 65 | Progressive cerebellar ataxia (HP:0002073) | 2.45332005 |
| 66 | Decreased circulating renin level (HP:0003351) | 2.44012144 |
| 67 | Spastic gait (HP:0002064) | 2.42161497 |
| 68 | Amblyopia (HP:0000646) | 2.39369671 |
| 69 | Germ cell neoplasia (HP:0100728) | 2.37125707 |
| 70 | Deformed sella turcica (HP:0002681) | 2.36710192 |
| 71 | Postural instability (HP:0002172) | 2.34471876 |
| 72 | Hemiplegia (HP:0002301) | 2.32034571 |
| 73 | Recurrent bacterial skin infections (HP:0005406) | 2.31978340 |
| 74 | Dysdiadochokinesis (HP:0002075) | 2.31172823 |
| 75 | Abnormality of the sella turcica (HP:0002679) | 2.29425097 |
| 76 | Lip pit (HP:0100267) | 2.27211943 |
| 77 | Amelogenesis imperfecta (HP:0000705) | 2.26109021 |
| 78 | Depression (HP:0000716) | 2.25952853 |
| 79 | Eczematoid dermatitis (HP:0000976) | 2.24387623 |
| 80 | Drooling (HP:0002307) | 2.24310160 |
| 81 | Excessive salivation (HP:0003781) | 2.24310160 |
| 82 | Impaired smooth pursuit (HP:0007772) | 2.23487270 |
| 83 | Macroorchidism (HP:0000053) | 2.23124291 |
| 84 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.22096003 |
| 85 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.22096003 |
| 86 | Abnormality of glycolipid metabolism (HP:0010969) | 2.22096003 |
| 87 | Recurrent abscess formation (HP:0002722) | 2.21209560 |
| 88 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.19181596 |
| 89 | Neonatal hypoglycemia (HP:0001998) | 2.14429223 |
| 90 | Hyperkalemia (HP:0002153) | 2.14326827 |
| 91 | Sparse lateral eyebrow (HP:0005338) | 2.13056179 |
| 92 | Impaired social interactions (HP:0000735) | 2.10839496 |
| 93 | Abnormal social behavior (HP:0012433) | 2.10839496 |
| 94 | Open mouth (HP:0000194) | 2.09422261 |
| 95 | Abnormality of the Achilles tendon (HP:0005109) | 2.07595180 |
| 96 | Lower limb muscle weakness (HP:0007340) | 2.07353028 |
| 97 | Resting tremor (HP:0002322) | 2.07106785 |
| 98 | Generalized hypotonia (HP:0001290) | 2.05666994 |
| 99 | Upper motor neuron abnormality (HP:0002127) | 2.04452064 |
| 100 | Achilles tendon contracture (HP:0001771) | 2.04158955 |
| 101 | Onion bulb formation (HP:0003383) | 2.03914047 |
| 102 | Abnormality of macrophages (HP:0004311) | 2.03568984 |
| 103 | Horizontal nystagmus (HP:0000666) | 2.02739308 |
| 104 | Bulbar palsy (HP:0001283) | 2.00962892 |
| 105 | Disproportionate short-trunk short stature (HP:0003521) | 1.99195464 |
| 106 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.98949032 |
| 107 | Abnormality of the renal cortex (HP:0011035) | 1.98482444 |
| 108 | Generalized myoclonic seizures (HP:0002123) | 1.98448136 |
| 109 | Cone-rod dystrophy (HP:0000548) | 1.98165452 |
| 110 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.97656551 |
| 111 | Mutism (HP:0002300) | 1.96883959 |
| 112 | Genetic anticipation (HP:0003743) | 1.95983573 |
| 113 | Amyloidosis (HP:0011034) | 1.95539615 |
| 114 | Azoospermia (HP:0000027) | 1.95401224 |
| 115 | Autoimmune thrombocytopenia (HP:0001973) | 1.93688783 |
| 116 | Protruding tongue (HP:0010808) | 1.93662110 |
| 117 | Hypoplasia of the odontoid process (HP:0003311) | 1.93306505 |
| 118 | Astrocytoma (HP:0009592) | 1.92064604 |
| 119 | Abnormality of the astrocytes (HP:0100707) | 1.92064604 |
| 120 | Obstructive sleep apnea (HP:0002870) | 1.91481854 |
| 121 | Intrahepatic cholestasis (HP:0001406) | 1.89408738 |
| 122 | Thin bony cortex (HP:0002753) | 1.89345128 |
| 123 | Truncal obesity (HP:0001956) | 1.89190713 |
| 124 | Abnormality of the prostate (HP:0008775) | 1.88460684 |
| 125 | Asymmetric septal hypertrophy (HP:0001670) | 1.87072524 |
| 126 | Gingivitis (HP:0000230) | 1.86713629 |
| 127 | Rapidly progressive (HP:0003678) | 1.85879976 |
| 128 | Apathy (HP:0000741) | 1.84577594 |
| 129 | Recurrent fungal infections (HP:0002841) | 1.83186442 |
| 130 | EMG: neuropathic changes (HP:0003445) | 1.83017832 |
| 131 | Epidermoid cyst (HP:0200040) | 1.83010117 |
| 132 | Generalized hypopigmentation of hair (HP:0011358) | 1.82674673 |
| 133 | Xanthomatosis (HP:0000991) | 1.82613826 |
| 134 | Sensory axonal neuropathy (HP:0003390) | 1.82141628 |
| 135 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.81887558 |
| 136 | Torticollis (HP:0000473) | 1.81790796 |
| 137 | Pseudobulbar signs (HP:0002200) | 1.79898816 |
| 138 | Ependymoma (HP:0002888) | 1.79756358 |
| 139 | Syncope (HP:0001279) | 1.78679865 |
| 140 | Abnormality of the musculature of the hand (HP:0001421) | 1.78634541 |
| 141 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.78577808 |
| 142 | Large earlobe (HP:0009748) | 1.78137833 |
| 143 | Loss of speech (HP:0002371) | 1.77853787 |
| 144 | Clonus (HP:0002169) | 1.77465346 |
| 145 | Gaze-evoked nystagmus (HP:0000640) | 1.77324204 |
| 146 | Deep venous thrombosis (HP:0002625) | 1.77051602 |
| 147 | Increased CSF protein (HP:0002922) | 1.76626887 |
| 148 | Tented upper lip vermilion (HP:0010804) | 1.76294661 |
| 149 | Abnormality of the periventricular white matter (HP:0002518) | 1.75951154 |
| 150 | Abnormality of the salivary glands (HP:0010286) | 1.75723330 |
| 151 | Stomatitis (HP:0010280) | 1.75624761 |
| 152 | Urinary urgency (HP:0000012) | 1.74562938 |
| 153 | Protuberant abdomen (HP:0001538) | 1.73930461 |
| 154 | Diplopia (HP:0000651) | 1.73472451 |
| 155 | Abnormality of binocular vision (HP:0011514) | 1.73472451 |
| 156 | Curly hair (HP:0002212) | 1.73310429 |
| 157 | Scanning speech (HP:0002168) | 1.72981736 |
| 158 | Widely spaced teeth (HP:0000687) | 1.72512331 |
| 159 | Impaired vibratory sensation (HP:0002495) | 1.71852954 |
| 160 | Bradykinesia (HP:0002067) | 1.71482468 |
| 161 | Septate vagina (HP:0001153) | 1.68851257 |
| 162 | Malnutrition (HP:0004395) | 1.68752722 |
| 163 | Recurrent cutaneous fungal infections (HP:0011370) | 1.66464594 |
| 164 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.66464594 |
| 165 | Gout (HP:0001997) | 1.65882429 |
| 166 | Abnormality of the odontoid process (HP:0003310) | 1.65704995 |
| 167 | Truncal ataxia (HP:0002078) | 1.65379330 |
| 168 | Poor eye contact (HP:0000817) | 1.64938844 |
| 169 | Cardiomegaly (HP:0001640) | 1.63687212 |
| 170 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.63327304 |
| 171 | Absent speech (HP:0001344) | 1.63195318 |
| 172 | Bundle branch block (HP:0011710) | 1.61894340 |
| 173 | Prolonged QT interval (HP:0001657) | 1.61438574 |
| 174 | Hamartoma of the eye (HP:0010568) | 1.61280726 |
| 175 | Abnormality of male internal genitalia (HP:0000022) | 1.60368686 |
| 176 | Heterotopia (HP:0002282) | 1.59318017 |
| 177 | Abdominal distention (HP:0003270) | 1.58605896 |
| 178 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 1.58276981 |
| 179 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.58203762 |
| 180 | Macroglossia (HP:0000158) | 1.56381757 |
| 181 | Agitation (HP:0000713) | 1.55659633 |
| 182 | Recurrent skin infections (HP:0001581) | 1.54949271 |
| 183 | Exercise-induced myalgia (HP:0003738) | 1.54177063 |
| 184 | Tibial bowing (HP:0002982) | 1.52380469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 3.82597956 |
| 2 | MAP3K9 | 3.42556126 |
| 3 | TRIB3 | 3.18894194 |
| 4 | GRK5 | 3.18464532 |
| 5 | ERN1 | 2.85607238 |
| 6 | NTRK3 | 2.70335567 |
| 7 | EPHA4 | 2.52697043 |
| 8 | FRK | 2.48923938 |
| 9 | NTRK1 | 2.35771350 |
| 10 | GRK6 | 2.19168010 |
| 11 | EEF2K | 2.03796788 |
| 12 | TYRO3 | 2.00280208 |
| 13 | PAK6 | 1.93394755 |
| 14 | MAP2K4 | 1.87848604 |
| 15 | WNK1 | 1.83648503 |
| 16 | MAPKAPK3 | 1.80246215 |
| 17 | DAPK2 | 1.74259759 |
| 18 | PKN2 | 1.71133246 |
| 19 | FER | 1.69814764 |
| 20 | KSR2 | 1.66406490 |
| 21 | MARK2 | 1.62864151 |
| 22 | MARK1 | 1.62178041 |
| 23 | MAP3K4 | 1.60104206 |
| 24 | RIPK1 | 1.57786764 |
| 25 | MAP3K13 | 1.51618933 |
| 26 | NTRK2 | 1.42111571 |
| 27 | RIPK4 | 1.41200953 |
| 28 | ACVR1B | 1.40076825 |
| 29 | MAP3K7 | 1.38747895 |
| 30 | SIK2 | 1.36888949 |
| 31 | BLK | 1.33092214 |
| 32 | MINK1 | 1.25344199 |
| 33 | CSF1R | 1.24168112 |
| 34 | TRPM7 | 1.23682186 |
| 35 | MAPK7 | 1.22382008 |
| 36 | ADRBK2 | 1.18354876 |
| 37 | GRK7 | 1.16662039 |
| 38 | TAOK3 | 1.12239457 |
| 39 | GRK1 | 1.11627373 |
| 40 | MAP3K2 | 1.11076086 |
| 41 | TGFBR2 | 1.11056538 |
| 42 | RPS6KA2 | 1.09893223 |
| 43 | PRKD3 | 1.09663349 |
| 44 | CAMK4 | 1.08324162 |
| 45 | TAOK1 | 1.07892433 |
| 46 | ICK | 1.05440244 |
| 47 | CAMK1G | 1.04288428 |
| 48 | MAP2K3 | 1.03021971 |
| 49 | PIK3CA | 1.02882333 |
| 50 | CAMKK1 | 1.01583836 |
| 51 | CDK5 | 1.01076762 |
| 52 | STK38 | 1.00431659 |
| 53 | CAMKK2 | 0.98300147 |
| 54 | PHKG1 | 0.98299567 |
| 55 | PHKG2 | 0.98299567 |
| 56 | MAP3K3 | 0.98146116 |
| 57 | FGFR3 | 0.97958862 |
| 58 | PRKAA2 | 0.97950352 |
| 59 | SIK1 | 0.97804743 |
| 60 | MOS | 0.96919849 |
| 61 | EPHB1 | 0.94951546 |
| 62 | PRKCH | 0.92448729 |
| 63 | PRKCI | 0.92120326 |
| 64 | MAPK13 | 0.91195347 |
| 65 | IRAK2 | 0.89428717 |
| 66 | OBSCN | 0.89415633 |
| 67 | PRKG2 | 0.86934416 |
| 68 | PRPF4B | 0.86913021 |
| 69 | PTK2 | 0.86370446 |
| 70 | MATK | 0.84731904 |
| 71 | HIPK2 | 0.84263802 |
| 72 | YES1 | 0.82878073 |
| 73 | MAP4K1 | 0.79954672 |
| 74 | CAMK1D | 0.77678798 |
| 75 | CHUK | 0.77220256 |
| 76 | FGFR4 | 0.77160272 |
| 77 | ALK | 0.76819230 |
| 78 | TYK2 | 0.76725441 |
| 79 | TTN | 0.76575716 |
| 80 | PAK3 | 0.74730247 |
| 81 | LMTK2 | 0.73848994 |
| 82 | SGK3 | 0.72633137 |
| 83 | RPS6KA6 | 0.71355484 |
| 84 | RET | 0.69820767 |
| 85 | INSRR | 0.69618750 |
| 86 | WNK4 | 0.66098996 |
| 87 | PINK1 | 0.65386458 |
| 88 | MAPK12 | 0.65225452 |
| 89 | JAK1 | 0.64753646 |
| 90 | MAP2K6 | 0.64146174 |
| 91 | IRAK1 | 0.64077517 |
| 92 | RPS6KL1 | 0.63875003 |
| 93 | RPS6KC1 | 0.63875003 |
| 94 | AKT3 | 0.62431117 |
| 95 | SGK494 | 0.61533758 |
| 96 | SGK223 | 0.61533758 |
| 97 | PIK3CG | 0.61135534 |
| 98 | PDK1 | 0.60924201 |
| 99 | TXK | 0.60638161 |
| 100 | PRKCG | 0.60305925 |
| 101 | STK11 | 0.59880855 |
| 102 | CASK | 0.58397956 |
| 103 | IKBKE | 0.58266015 |
| 104 | MAP3K1 | 0.57828940 |
| 105 | MAP2K7 | 0.57396700 |
| 106 | STK39 | 0.57237140 |
| 107 | TNK2 | 0.56365299 |
| 108 | DYRK1A | 0.56119392 |
| 109 | KSR1 | 0.54973113 |
| 110 | ADRBK1 | 0.54151402 |
| 111 | CAMK1 | 0.54115519 |
| 112 | ZAP70 | 0.53713244 |
| 113 | PDPK1 | 0.53144954 |
| 114 | MAP3K14 | 0.52677108 |
| 115 | CSK | 0.51136131 |
| 116 | ERBB2 | 0.50826626 |
| 117 | FYN | 0.50692310 |
| 118 | JAK2 | 0.50637431 |
| 119 | PRKAA1 | 0.50459630 |
| 120 | RPS6KA3 | 0.50124070 |
| 121 | SGK1 | 0.48563112 |
| 122 | BMX | 0.48461920 |
| 123 | UHMK1 | 0.48025790 |
| 124 | DMPK | 0.47916134 |
| 125 | NEK6 | 0.47379325 |
| 126 | MAP3K11 | 0.46023124 |
| 127 | HCK | 0.45030519 |
| 128 | SGK2 | 0.44498417 |
| 129 | SYK | 0.44436793 |
| 130 | PKN1 | 0.44302786 |
| 131 | MAPK10 | 0.44176185 |
| 132 | PRKD2 | 0.44013492 |
| 133 | IRAK4 | 0.42876632 |
| 134 | EPHA2 | 0.42467720 |
| 135 | FES | 0.42223346 |
| 136 | IKBKB | 0.42135453 |
| 137 | PRKCZ | 0.42129054 |
| 138 | CDC42BPA | 0.42012353 |
| 139 | PRKACG | 0.41435104 |
| 140 | KIT | 0.41011417 |
| 141 | PTK2B | 0.40391475 |
| 142 | STK10 | 0.40277651 |
| 143 | CDK15 | 0.39805969 |
| 144 | ITK | 0.38725150 |
| 145 | PRKCQ | 0.38360059 |
| 146 | MTOR | 0.38061434 |
| 147 | PRKD1 | 0.37736881 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.57067830 |
| 2 | GABAergic synapse_Homo sapiens_hsa04727 | 1.90319985 |
| 3 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.86230766 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 1.85424750 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.81046290 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.80079820 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 1.78578488 |
| 8 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.75149174 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.73039272 |
| 10 | Salivary secretion_Homo sapiens_hsa04970 | 1.58740424 |
| 11 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.55383328 |
| 12 | Circadian entrainment_Homo sapiens_hsa04713 | 1.53808005 |
| 13 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.49273215 |
| 14 | Morphine addiction_Homo sapiens_hsa05032 | 1.46909052 |
| 15 | Olfactory transduction_Homo sapiens_hsa04740 | 1.46300198 |
| 16 | Long-term potentiation_Homo sapiens_hsa04720 | 1.45181506 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.42401079 |
| 18 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.39721892 |
| 19 | Bile secretion_Homo sapiens_hsa04976 | 1.39454270 |
| 20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.37625265 |
| 21 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.28195669 |
| 22 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.27270955 |
| 23 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.25099742 |
| 24 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.24430404 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.21885668 |
| 26 | Lysine degradation_Homo sapiens_hsa00310 | 1.17832455 |
| 27 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.17789037 |
| 28 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.16707348 |
| 29 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.16309819 |
| 30 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.15920151 |
| 31 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.15375802 |
| 32 | Renin secretion_Homo sapiens_hsa04924 | 1.14419781 |
| 33 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.14250596 |
| 34 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.13287789 |
| 35 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.12812273 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.12807184 |
| 37 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.12738352 |
| 38 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.10684619 |
| 39 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.09778279 |
| 40 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.08852481 |
| 41 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.07880178 |
| 42 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.07296841 |
| 43 | Platelet activation_Homo sapiens_hsa04611 | 1.06589782 |
| 44 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.06517309 |
| 45 | Long-term depression_Homo sapiens_hsa04730 | 1.03872576 |
| 46 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.02753569 |
| 47 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.02134744 |
| 48 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.01479777 |
| 49 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.00109651 |
| 50 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.99105808 |
| 51 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.97960485 |
| 52 | Tuberculosis_Homo sapiens_hsa05152 | 0.97260209 |
| 53 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.96372925 |
| 54 | ABC transporters_Homo sapiens_hsa02010 | 0.94803482 |
| 55 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.94246093 |
| 56 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.92687336 |
| 57 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.90621808 |
| 58 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.89323078 |
| 59 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.89028813 |
| 60 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.88257877 |
| 61 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.87512861 |
| 62 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.85358750 |
| 63 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.84595414 |
| 64 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.84554093 |
| 65 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.84028926 |
| 66 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.83667669 |
| 67 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.82528103 |
| 68 | Cocaine addiction_Homo sapiens_hsa05030 | 0.81476126 |
| 69 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.79291902 |
| 70 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.79275103 |
| 71 | Endometrial cancer_Homo sapiens_hsa05213 | 0.77088591 |
| 72 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.76421030 |
| 73 | Prostate cancer_Homo sapiens_hsa05215 | 0.75514427 |
| 74 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.75351590 |
| 75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.74858946 |
| 76 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.74746702 |
| 77 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74393902 |
| 78 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.74311274 |
| 79 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.73989276 |
| 80 | Leishmaniasis_Homo sapiens_hsa05140 | 0.73567436 |
| 81 | Axon guidance_Homo sapiens_hsa04360 | 0.72963565 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.72929876 |
| 83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.71765169 |
| 84 | Histidine metabolism_Homo sapiens_hsa00340 | 0.71352113 |
| 85 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.68986627 |
| 86 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.68662211 |
| 87 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.68449541 |
| 88 | Gap junction_Homo sapiens_hsa04540 | 0.67421664 |
| 89 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.66585419 |
| 90 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.66073858 |
| 91 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.65613168 |
| 92 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65474446 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65037050 |
| 94 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64966621 |
| 95 | Hepatitis C_Homo sapiens_hsa05160 | 0.64541136 |
| 96 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.64306273 |
| 97 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.64078573 |
| 98 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.62624780 |
| 99 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.61658851 |
| 100 | Galactose metabolism_Homo sapiens_hsa00052 | 0.60668805 |
| 101 | Glioma_Homo sapiens_hsa05214 | 0.60635909 |
| 102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60324301 |
| 103 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.59731896 |
| 104 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.59632937 |
| 105 | Insulin resistance_Homo sapiens_hsa04931 | 0.58753684 |
| 106 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.57173525 |
| 107 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55903210 |
| 108 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.55829017 |
| 109 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.55606967 |
| 110 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55559343 |
| 111 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.55390200 |
| 112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55169737 |
| 113 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.54874745 |
| 114 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54142892 |
| 115 | Mineral absorption_Homo sapiens_hsa04978 | 0.53628562 |
| 116 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53303032 |
| 117 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.53226712 |
| 118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53121059 |
| 119 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.52382184 |
| 120 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.52363201 |
| 121 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50934949 |
| 122 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49607877 |
| 123 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49519979 |
| 124 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.49174164 |
| 125 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.47643462 |
| 126 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.47555179 |
| 127 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.46777840 |
| 128 | Endocytosis_Homo sapiens_hsa04144 | 0.46705414 |
| 129 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.46032428 |
| 130 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.42983703 |
| 131 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42555436 |
| 132 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.41578163 |
| 133 | Lysosome_Homo sapiens_hsa04142 | 0.40732533 |
| 134 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.39848126 |
| 135 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.39834247 |
| 136 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.39829472 |
| 137 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.39336718 |
| 138 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.39335995 |

